论文部分内容阅读
目的:比较伽马射线放射疗法与常规药物化疗法对原发性肝癌患者症状缓解的疗效与安全性。方法:选取2014年6月—2015年9月期间收治的的原发性肝癌患者31例,根据就诊顺序将其随机分为对照组(16例)和观察组(15例);观察组患者给予伽马射线立体定向放射治疗,对照组患者给予顺铂或多柔比星(常规药物)化疗治疗,比较两组患者分别治疗后的症状缓解率和安全性。结果:观察组患者治疗后的症状缓解率为73.33%高于对照组为50.00%(P<0.05),不良反应的发生率为26.67%低于对照组为75.00%(P<0.05)。结论:采用伽马射线放射疗法治疗原发性肝癌患者,症状缓解与安全性优于常规药物化疗法。
Objective: To compare the efficacy and safety of gamma ray radiotherapy and conventional chemotherapy in the treatment of patients with primary liver cancer. Methods: Totally 31 patients with primary hepatocellular carcinoma (HCC) who were admitted to our hospital from June 2014 to September 2015 were randomly divided into control group (n = 16) and observation group (n = 15) according to the order of treatment. Patients in observation group Gamma-ray stereotactic radiotherapy, control group patients given cisplatin or doxorubicin (conventional drug) chemotherapy, the two groups of patients were compared after treatment, the rate of symptom relief and safety. Results: The symptom relief rate was 73.33% in the observation group and 50.00% in the control group (P <0.05). The incidence of adverse reactions was 26.67% in the observation group and 75.00% in the control group (P <0.05). Conclusion: The treatment of primary liver cancer with gamma-ray radiotherapy is superior to conventional chemotherapy in the relief and safety of symptoms.